Kelly Holmes
Family · Hickory, NCNPI 1548991565
Payments from drug & device makers
Across 1,127 payments — averaging $49.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$34K
- TG Therapeutics, Inc.$3K
- AbbVie$2K
- MDD US Operations, LLC$2K
- Abbott$1K
- EMD Serono, Inc.$1K
- plus $12K from 54 others
What the payments were for
- Consulting fees$1,8103%
- Speaking & faculty fees$27,66150%
- Travel & lodging$5,47710%
- Food & beverage$19,79536%
- Education$7451%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$30,163
- BRIUMVI$2,250
- INFINITY$1,184
- GOCOVRI$756
- VNS Therapy$575
- Epidiolex$346
- VRAYLAR$249
- QULIPTA$116
- UBRELVY$116
- ULTOMIRIS$100
How this compares
$55,488 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 67 | $715,781 |
| BetaseronInterferon Beta-1b | 24 | $232,902 |
| ZeposiaOzanimod Hydrochloride | 12 | $107,212 |
| NuplazidPimavanserin Tartrate | 16 | $98,748 |
| Nurtec OdtRimegepant Sulfate | 54 | $71,398 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 55 | $47,696 |
| QuliptaAtogepant | 40 | $47,203 |
| NamzaricMemantine Hcl/Donepezil Hcl | 35 | $42,956 |
| VraylarCariprazine Hcl | 28 | $41,122 |
| BriviactBrivaracetam | 25 | $40,012 |
| GocovriAmantadine Hcl | 18 | $35,580 |
| UbrelvyUbrogepant | 17 | $25,708 |
| XcopriCenobamate | 13 | $24,976 |
| Dalfampridine ErDalfampridine | 24 | $14,346 |
| Aimovig AutoinjectorErenumab-Aooe | 19 | $14,322 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $33,997 | $715,78167 claims |
| AbbVieQulipta, Namzaric, Vraylar, Ubrelvy, Botox | $2,198 | $182,173150 claims |
| E.r. Squibb & Sons, L.L.C.Zeposia | $58 | $107,21212 claims |
| Acadia Pharmaceuticals IncNuplazid | $788 | $98,74816 claims |
| PfizerNurtec Odt | $600 | $71,39854 claims |
| UCB, Inc.Briviact | $938 | $40,01225 claims |
| MDD US Operations, LLCGocovri | $1,595 | $35,58018 claims |
| SK Life Science, Inc.Xcopri | $243 | $24,97613 claims |
| Eisai Inc.Fycompa | $198 | $12,77111 claims |
| Lilly USA, LLCReyvow | $490 | $10,23714 claims |
| Upsher-smith Laboratories LLCTopiramate | $15 | $1,11374 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,522 family providers in North Carolina.
Other family in Hickory
- Tanya DyerHickory$21K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.